Daniel Davies, MD
Cardiovascular Disease · Pittsburgh, PANPI 1316471220
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,670 of the $8,639 with a category attached, or 65.6%. Alnylam Pharmaceuticals Inc. accounts for 83.9% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $8,296, more than ten times the $31 reported in 2023.
Across 46 payments — averaging $187.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alnylam Pharmaceuticals Inc.$7K
- E.r. Squibb & Sons, L.L.C.$453
- AstraZeneca$374
- Bridgebio Pharma, Inc.$252
- Pfizer$128
- Boehringer Ingelheim$80
- plus $100 from 3 others
What the payments were for
- Consulting fees$5,67066%
- Travel & lodging$1,09113%
- Food & beverage$1,87822%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 11 | $7,252 |
| E.r. Squibb & Sons, L.L.C. | 9 | $453 |
| AstraZeneca | 8 | $374 |
| Bridgebio Pharma, Inc. | 3 | $252 |
| Pfizer | 7 | $128 |
| Boehringer Ingelheim | 4 | $80 |
| Bayer | 2 | $40 |
| ZOLL Circulation Inc | 1 | $31 |
| Lantheus Medical Imaging, Inc. | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,639 in reported general payments places this provider in the 80th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Pittsburgh
- George GabrielPittsburgh$563K
- Mark GreathousePittsburgh$243K
- Brian HenryPittsburgh$224K
- Kent VolosinPittsburgh$190K
- Victor FarahPittsburgh$98K
- Moneal ShahPittsburgh$90K
- Stephen ChanPittsburgh$70K
- Hemal GadaWormleysburg$1.8M
- Benjamin KalsmithPgh$1.7M
- Peter KoweyWynnewood$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.